Aerie Pharmaceuticals, Inc. (AERI) Elects James Mazzo To The Company's Board Of Directors

Aerie Pharmaceuticals, Inc. (AERI) Elects James Mazzo To The Company's Board Of Directors

Aerie Pharmaceuticals, Inc. (Nasdaq:AERI) today announced that James Mazzo has been elected to the Company's Board of Directors, effective June 11, 2014. Mr. Mazzo brings an impressive track record of leadership roles within the ophthalmic industry, including as the former head of Abbott Medical Optics, and currently serves as Operating Partner at Versant Ventures. 

Suggested Articles

After early threats, the FDA finished reviewing the company's response to a citation for data manipulation and decided not to take any further action.

China is quickly getting back up to speed with API production but reports freight bottlenecks are slowing deliveries.

Mylan and Pfizer have already postponed the close of their generic merger amid COVID-19 concerns. Now the pair is hoping to speed up EU review.